Nature Medicine | Spoonful of Medicine
Ahead of schedule, first hedgehog inhibitor drug gets the green light
In a landmark approval a month and half ahead of schedule, the first targeted treatment for basal cell carcinoma, the most common form of skin cancer, won approval today from the US Food and Drug Administration.
Recent comments
Real-time tissue analysis could guide brain tumor surgery
Bundled RNA balls silence brain cancer gene expression
Ebola outbreak in West Africa lends urgency to recently-funded research